News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,990 Results
Type
Article (43058)
Company Profile (322)
Press Release (663610)
Section
Business (211174)
Career Advice (2065)
Deals (36320)
Drug Delivery (83)
Drug Development (81845)
Employer Resources (171)
FDA (16558)
Job Trends (15242)
News (354575)
Policy (33281)
Tag
Academia (2681)
Africa (751)
Alliances (51981)
Alzheimer's disease (1161)
Approvals (16483)
Arizona (183)
Artificial intelligence (84)
Asia (39430)
Australia (6530)
Bankruptcy (355)
Best Places to Work (11559)
Biosimilars (64)
Biotechnology (228)
C2C Services and Suppliers (84304)
California (1857)
Canada (919)
Cancer (463)
Career advice (1725)
Cell therapy (125)
China (148)
Clinical research (63927)
Collaboration (141)
Colorado (75)
Compensation (77)
Connecticut (74)
COVID-19 (2569)
Cystic fibrosis (75)
Data (283)
Diabetes (81)
Diagnostics (6228)
Drug pricing (64)
Earnings (85219)
Employer resources (147)
Europe (85872)
Events (112345)
Executive appointments (148)
FDA (16767)
Florida (262)
Funding (143)
Gene therapy (94)
Georgia (67)
GLP-1 (523)
Government (4388)
Healthcare (19317)
Hotbed/Location (495040)
Illinois (269)
Indiana (149)
Infectious disease (2597)
Inflammatory bowel disease (91)
Interviews (317)
IPO (16531)
Job creations (3807)
Job search strategy (1483)
Kansas (97)
Layoffs (406)
Legal (8046)
Lung cancer (107)
Manufacturing (85)
Maryland (391)
Massachusetts (1539)
Medical device (13752)
Medtech (13757)
Mergers & acquisitions (19640)
Metabolic disorders (246)
Michigan (135)
Minnesota (221)
Neuroscience (1302)
New Jersey (571)
New York (576)
NextGen Class of 2024 (6810)
Non-profit (4591)
North Carolina (617)
Northern California (818)
Obesity (145)
Ohio (105)
Opinion (182)
Patents (72)
Pennsylvania (574)
People (58004)
Pharmaceutical (69)
Phase I (19957)
Phase II (28136)
Phase III (20938)
Pipeline (104)
Postmarket research (2565)
Preclinical (8557)
Press Release (71)
Rare diseases (131)
Real estate (6204)
Regulatory (21741)
Research institute (2443)
Resumes & cover letters (357)
South America (1142)
Southern California (745)
Startups (3822)
Texas (239)
United States (8588)
Vaccines (495)
Washington State (255)
Weight loss (128)
Date
Today (171)
Last 7 days (687)
Last 30 days (2259)
Last 365 days (38395)
2024 (26626)
2023 (41134)
2022 (52397)
2021 (56997)
2020 (55616)
2019 (48410)
2018 (36443)
2017 (33543)
2016 (33139)
2015 (39358)
2014 (32941)
2013 (27986)
2012 (30242)
2011 (30847)
2010 (28809)
706,990 Results for "vaxess technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference 2024
Helius Medical Technologies, Inc. announced that it will participate in the Spring MicroCap Rodeo Conference to be held on Thursday, June 6th in NYC.
May 31, 2024
·
6 min read
Business
GT Medical Technologies, Inc. Appoints Two Industry Medical Device Veterans to Key Leadership Positions
GT Medical Technologies, Inc. today announced two significant additions to its leadership team: Tom Moore as Chief Commercial Officer and Sandeep Yadav as Chief Financial Officer.
June 20, 2024
·
2 min read
Press Releases
GT Medical Technologies, Inc. Secures $35 Million Venture Loan Facility from Horizon Technology Finance
September 12, 2024
·
4 min read
Pharm Country
Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
Helius Medical Technologies, Inc. announced the completion of site participation enrollment for its stroke registrational program in the U.S. with the addition of REHABOLOGYM, Neurology Center of New England, and MGH Institute of Health Professions.
June 17, 2024
·
10 min read
Lone Star Bio
Retractable Technologies, Inc. Reports Results for 2023
Retractable Technologies, Inc. reports the following information relating to the year ended December 31, 2023.
March 29, 2024
·
4 min read
Business
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results
Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced results for the quarter ended March 31, 2024.
May 13, 2024
·
10 min read
Business
Retractable Technologies, Inc. Results for the Period Ended March 31, 2024
Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.6 million for the first three months of 2024 and an operating loss of nearly $3.0 million for the period, as compared to total net sales for the same period last year of $11.0 million and an operating loss of $2.7 million.
May 15, 2024
·
5 min read
Pharm Country
Helius Medical Technologies, Inc. Announces Third-Party Reimbursement for PoNS® from Major Insurance Carrier
Helius Medical Technologies, Inc., a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, announced the first third-party reimbursement from a major insurance carrier for the Company’s Portable Neuromodulation Stimulator device.
May 29, 2024
·
5 min read
Business
GT Medical Technologies, Inc. and Theragenics Corporation Forge Distribution Partnership for Cesium-131
GT Medical Technologies, Inc. today announced it has entered into a strategic distribution partnership with Theragenics Corporation® (Theragenics), a global leader in minimally invasive brachytherapy.
May 1, 2024
·
4 min read
Business
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior ExchangeStrategic Audit Completion Set to Enhance BioStem Technologies’ Market Position and Shareholder Value
BioStem Technologies Inc. today announced the successful completion of comprehensive audits for fiscal years 2022 and 2023.
April 24, 2024
·
5 min read
1 of 70,699
Next
